Global X S&P 500 Covered Call UCITS ETF (LON:XYLU)
14.70
-0.08 (-0.53%)
Last updated: Sep 2, 2025, 2:35 PM BST
-0.53% (1Y)
Assets | 79.00M |
Expense Ratio | 0.45% |
PE Ratio | 24.35 |
Dividend (ttm) | 1.13 |
Dividend Yield | 10.21% |
Ex-Dividend Date | Aug 28, 2025 |
Payout Frequency | Monthly |
Payout Ratio | 184.65% |
1-Year Return | +6.28% |
Volume | 10,507 |
Open | 14.79 |
Previous Close | 14.78 |
Day's Range | 14.69 - 14.88 |
52-Week Low | 13.00 |
52-Week High | 17.00 |
Beta | n/a |
Holdings | 30 |
Inception Date | Jul 11, 2023 |
About XYLU
XYLU.L was created on 2023-07-11 by Global X. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 104.13m in AUM and 33 holdings. The Global X S&P 500 Covered Call UCITS ETF (XYLU.L LN) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite 15% WHT Index.
Asset Class Equity
Category Large Cap
Region North America
Stock Exchange London Stock Exchange
Ticker Symbol XYLU
Provider Global X
Index Tracked S&P 500
Performance
XYLU had a total return of 6.28% in the past year, including dividends. Since the fund's inception, the average annual return has been 19.24%.
Top 10 Holdings
49.46% of assetsName | Symbol | Weight |
---|---|---|
CVS Health Corporation | CVS | 5.20% |
Alphabet Inc. | GOOGL | 5.08% |
Eli Lilly and Company | LLY | 5.07% |
Phillips 66 | PSX | 5.04% |
Microsoft Corporation | MSFT | 4.94% |
Cummins Inc. | CMI | 4.90% |
Regeneron Pharmaceuticals, Inc. | REGN | 4.84% |
Aflac Incorporated | AFL | 4.84% |
Applied Materials, Inc. | AMAT | 4.79% |
Meta Platforms, Inc. | META | 4.77% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Aug 28, 2025 | £0.08585 | Sep 5, 2025 |
Jul 31, 2025 | £0.08722 | Aug 8, 2025 |
Jul 3, 2025 | £0.10449 | Jul 11, 2025 |
May 30, 2025 | £0.10858 | Jun 6, 2025 |
May 8, 2025 | £0.10694 | May 16, 2025 |
Apr 3, 2025 | £0.11475 | Apr 11, 2025 |